This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yao, J. Articles by Polyak, K. Search for Related Content PubMed PubMed Citation Articles by Yao, J. Articles by Polyak, K.

Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression

Departments of ¹ Medical Oncology and ² Biostatistical Sciences, Dana-Farber Cancer Institute; ³ Department of Pathology, Brigham and Women's Hospital; ⁴ Harvard Medical School; and ⁵ Harvard School of Public Health, Boston, Massachusetts; ⁶ Program in Computational Biology, Fred Hutchinson Cancer Center, Seattle, Washington; and ⁷ Department of Surgery, Duke University Medical Center, Durham, North Carolina

Requests for reprints: Kornelia Polyak, D740C, Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street D740C, Boston, MA 02115. Phone: 617-632-2106; Fax: 617-632-4005; E-mail: kornelia_polyak{at}dfci.harvard.edu.

To identify genetic changes involved in the progression of breast carcinoma, we did cDNA array comparative genomic hybridization (CGH) on a panel of breast tumors, including 10 ductal carcinoma in situ (DCIS), 18 invasive breast carcinomas, and two lymph node metastases. We identified 49 minimal commonly amplified regions (MCRs) that included known (1q, 8q24, 11q13, 17q21-q23, and 20q13) and several uncharacterized (12p13 and 16p13) regional copy number gains. With the exception of the 17q21 (ERBB2) amplicon, the overall frequency of copy number alterations was higher in invasive tumors than that in DCIS, with several of them present only in invasive cancer. Amplification of candidate loci was confirmed by quantitative PCR in breast carcinomas and cell lines. To identify putative targets of amplicons, we developed a method combining array CGH and serial analysis of gene expression (SAGE) data to correlate copy number and expression levels for each gene within MCRs. Using this approach, we were able to distinguish a few candidate targets from a set of coamplified genes. Analysis of the 12p13-p12 amplicon identified four putative targets: TEL/ETV6, H2AFJ, EPS8, and KRAS2. The amplification of all four candidates was confirmed by quantitative PCR and fluorescence in situ hybridization, but only H2AFJ and EPS8 were overexpressed in breast tumors with 12p13 amplification compared with a panel of normal mammary epithelial cells. These results show the power of combined array CGH and SAGE analysis for the identification of candidate amplicon targets and identify H2AFJ and EPS8 as novel putative oncogenes in breast cancer. (Cancer Res 2006; 66(8): 4065-78)

This article has been cited by other articles:

				S. Frohling and H. Dohner Chromosomal Abnormalities in Cancer N. Engl. J. Med., August 14, 2008; 359(7): 722 - 734. [Full Text] [PDF]

				V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454. [Abstract] [Full Text] [PDF]

				F. Rapaport, E. Barillot, and J.-P. Vert Classification of arrayCGH data using fused SVM Bioinformatics, July 1, 2008; 24(13): i375 - i382. [Abstract] [Full Text] [PDF]

				Y.-J. Chen, M.-R. Shen, Y.-J. Chen, M.-C. Maa, and T.-H. Leu Eps8 decreases chemosensitivity and affects survival of cervical cancer patients Mol. Cancer Ther., June 1, 2008; 7(6): 1376 - 1385. [Abstract] [Full Text] [PDF]

				H. Lee, S. W. Kong, and P. J. Park Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes Bioinformatics, April 1, 2008; 24(7): 889 - 896. [Abstract] [Full Text] [PDF]

				J. Adelaide, P. Finetti, I. Bekhouche, L. Repellini, J. Geneix, F. Sircoulomb, E. Charafe-Jauffret, N. Cervera, J. Desplans, D. Parzy, et al. Integrated Profiling of Basal and Luminal Breast Cancers Cancer Res., December 15, 2007; 67(24): 11565 - 11575. [Abstract] [Full Text] [PDF]

				C. Bradley, R. van der Meer, N. Roodi, H. Yan, M. B. Chandrasekharan, Z.-W. Sun, R. L. Mernaugh, and F. F. Parl Carcinogen-induced histone alteration in normal human mammary epithelial cells Carcinogenesis, October 1, 2007; 28(10): 2184 - 2192. [Abstract] [Full Text] [PDF]

				A. Buness, R. Kuner, M. Ruschhaupt, A. Poustka, H. Sultmann, and A. Tresch Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer Bioinformatics, September 1, 2007; 23(17): 2273 - 2280. [Abstract] [Full Text] [PDF]

				S. Y. Kim and W. C. Hahn Cancer genomics: integrating form and function Carcinogenesis, July 1, 2007; 28(7): 1387 - 1392. [Abstract] [Full Text] [PDF]

				J. Climent, P. Dimitrow, J. Fridlyand, J. Palacios, R. Siebert, D. G. Albertson, J. W. Gray, D. Pinkel, A. Lluch, and J. A. Martinez-Climent Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer Cancer Res., January 15, 2007; 67(2): 818 - 826. [Abstract] [Full Text] [PDF]